Otsuka is voluntarily recalling certain lots of ABILIFY® (aripiprazole) Tablets due to cross-contamination from extremely small amounts of another active pharmaceutical ingredient previously manufactured on the same equipment. Based on sample testing performed, there is no material patient risk associated with the trace level of contamination found. The voluntary recall has been initiated by Otsuka out of an abundance of caution, with the knowledge of the U.S. Food and Drug Administration. This recall is limited to the United States.

Consumers who have a product that is being recalled and who have concerns, should consult with their healthcare provider or pharmacy. Adverse reactions or quality problems experienced with the use of this product should be reported.

Otsuka America Pharmaceutical, Inc. can be reached by phone at 1-833-468-7852 Monday – Friday, 9 a.m. – 5 p.m. Eastern Time or by email: global_intake@otsuka-us.com or ProductComplaints@otsuka-us.com. The FDA's MedWatch Adverse Event Reporting program can be reached either online or by phone. To complete and submit the report Online: www.fda.gov/medwatch/report.htm or call 1-800-332-1088.

Read more here: https://www.otsuka-us.com/news/otsuka-us-voluntary-recall

April 2024 01US24EBC0008

Ten innovators from around the world will participate in the first-ever AGE-WELL Pitch Competition: Technology to Support People with Dementia. The competition will showcase a wide range of technology solutions that address the many challenges faced by people living with dementia. Each finalist will deliver a fast-paced, five-minute presentation to a panel of expert judges who will select a winner.  The Global Council on Alzheimer’s Disease (GCAD), an initiative created by Otsuka America Pharmaceutical, Inc., is co-hosting the event with AGE-WELL NCE Inc.
The finalists were chosen by a group of experts in dementia and Alzheimer’s including physicians, researchers, caregivers, and industry leaders.  Products being pitched range from those that aim to improve communication between family members and healthcare providers to those that provide transportation and safety through home monitoring and advanced tracking devices.
The pitch event will be held at the Royal York Hotel, 100 Front Street W, Toronto, Saturday, July 23 from 6:00 – 9:30 p.m. EST.
The event is sponsored by Otsuka America Pharmaceutical, Inc., Aging2.0, AGE-WELL NCE, the Ontario Brain Institute, and the Women’s Brain Health Initiative.
For more information about the event, visit http://agewell-nce.ca/archives/4414
July 2016     01US16EUC0076